In this study, TAP serum and CEA were used to detect thyroid nodules in patients with thyroid nodules of type IV and above, with the aim of investigating the risk assessment of thyroid cancer in patients with thyroid nodules of type IV and above. The gene discussed is CEACAM5; the disease is thyroid cancer.